We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$72.6B
AUM Growth
+$2.24B
Cap. Flow
-$1.27B
Cap. Flow %
-1.76%
Top 10 Hldgs %
47.27%
Holding
771
New
75
Increased
302
Reduced
302
Closed
60

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$363M
2
BA icon
Boeing
BA
+$246M
3
SHOP icon
Shopify
SHOP
+$141M
4
SBUX icon
Starbucks
SBUX
+$138M
5
TMO icon
Thermo Fisher Scientific
TMO
+$94.6M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Communication Services 18.21%
3 Consumer Discretionary 15.44%
4 Healthcare 13.43%
5 Financials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
51
Accenture
ACN
$108B
$185M 0.25%
608,366
-86,483
-12% -$26.5M
YUMC icon
52
Yum China
YUMC
$16.3B
$177M 0.24%
5,726,447
+3,752
+0.1% +$137K
GS icon
53
Goldman Sachs
GS
$303B
$168M 0.23%
371,467
+6,602
+2% +$2.9M
LSGR icon
54
Natixis Loomis Sayles Focused Growth ETF
LSGR
$897M
$167M 0.23%
4,905,674
+621,276
+15% +$19.8M
IQV icon
55
IQVIA
IQV
$39.3B
$162M 0.22%
768,037
-61,490
-7% -$14M
ARM icon
56
Arm
ARM
$302B
$159M 0.22%
972,087
-20,212
-2% -$2.51M
ADBE icon
57
Adobe
ADBE
$105B
$159M 0.22%
285,912
+31,787
+13% +$15.4M
MELI icon
58
Mercado Libre
MELI
$92.3B
$159M 0.22%
96,620
-1,681
-2% -$2.65M
ALNY icon
59
Alnylam Pharmaceuticals
ALNY
$29.3B
$138M 0.19%
569,282
-12,569
-2% -$1.98M
WFRD icon
60
Weatherford International
WFRD
$6.22B
$136M 0.19%
1,108,732
-116,864
-10% -$14M
TXN icon
61
Texas Instruments
TXN
$261B
$132M 0.18%
679,636
+11,806
+2% +$2.18M
FANG icon
62
Diamondback Energy
FANG
$52.7B
$126M 0.17%
629,541
-254,990
-29% -$50.6M
TT icon
63
Trane Technologies
TT
$106B
$118M 0.16%
358,428
+6,259
+2% +$1.99M
HLNE icon
64
Hamilton Lane
HLNE
$5.57B
$98.5M 0.14%
796,922
-56,292
-7% -$6.58M
MMSI icon
65
Merit Medical Systems
MMSI
$5.32B
$95.8M 0.13%
1,114,050
+2,852
+0.3% +$224K
HQY icon
66
HealthEquity
HQY
$8.75B
$95M 0.13%
1,101,980
+171,114
+18% +$13.8M
MTSI icon
67
MACOM Technology Solutions
MTSI
$23.7B
$86.8M 0.12%
778,678
-30,962
-4% -$3.16M
ATI icon
68
ATI
ATI
$31B
$84.1M 0.12%
1,516,932
-111,291
-7% -$6.24M
INSM icon
69
Insmed
INSM
$28.6B
$82.2M 0.11%
1,226,726
-265,068
-18% -$10.3M
AZEK
70
DELISTED
The AZEK Co
AZEK
$81.8M 0.11%
1,941,156
-515,217
-21% -$23.8M
MEDP icon
71
Medpace
MEDP
$16.5B
$79M 0.11%
191,918
+33,144
+21% +$13.1M
ACA icon
72
Arcosa
ACA
$7.11B
$78.2M 0.11%
937,146
-34,412
-4% -$2.87M
PRCT icon
73
Procept Biorobotics
PRCT
$1.17B
$77.1M 0.11%
1,261,608
-89,392
-7% -$5.32M
KBR icon
74
KBR
KBR
$4.8B
$76.6M 0.11%
1,193,682
+209,305
+21% +$13.5M
RBC icon
75
RBC Bearings
RBC
$18B
$74.5M 0.1%
276,057
-19,390
-7% -$5.21M

Similar funds

Loomis, Sayles & Company's Q2 2024 Portfolio in Review

As of Q2 2024, Loomis, Sayles & Company held 771 positions worth $72.6B, up 3.2% from $70.3B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loomis, Sayles & Company's Q2 2024 filing shows 75 new, 302 increased, 302 reduced and 60 closed positions. Its largest new stake was Onterris Inc: 748,551 shares worth $33.4M. The largest sale was Bank of America Series L, an estimated $985M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Loomis, Sayles & Company's largest Q2 2024 buy was Onterris Inc: 748,551 shares worth $33.4M.
  • Loomis, Sayles & Company added most to Tesla in Q2 2024, an estimated $363M increase.
  • Loomis, Sayles & Company's biggest Q2 2024 reduction was Bank of America Series L, cutting an estimated $985M.
  • Loomis, Sayles & Company fully exited Axonics, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 47% of its $72.6B portfolio in Q2 2024.
  • Loomis, Sayles & Company opened 75 new positions and closed 60 in Q2 2024.
  • Loomis, Sayles & Company's portfolio value rose 3.2% quarter-over-quarter to $72.6B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2024, filed 13 Aug 2024.